Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion type Assertion NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_head.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion description "[Three of its targets: SRSF2, PLAU and HIC2, work in concert to relay the miR-193a-3p's impact on the bladder cancer chemoresistance by modulating the activities of the following five signaling pathways: DNA damage, Notch, NF-?B, Myc/Max, and Oxidative Stress.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_provenance.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion evidence source_evidence_literature NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_provenance.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion SIO_000772 25188512 NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_provenance.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion wasDerivedFrom befree-2016 NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_provenance.
- NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_assertion wasGeneratedBy ECO_0000203 NP1216808.RAdOGpL5qMnNNXUC62CUHEPBYVstNCNY64jOyQMlTrcFg130_provenance.